Abstract: The present disclosure relates to processes for producing hydrocarbon fuels from lignocellulosic biomass. A process may include introducing biomass to a pretreatment system, and a first separation system forming a pentose-rich stream and a pentose-lean stream. The pentose-lean stream may be introduced to a hydrolysis system forming a hydrolysate and the hydrolysate introduced to a second separation system forming a hexose-rich stream and a lignin stream. Additionally, at least one of the pentose-rich stream or the hexose-rich stream may be introduced to a bioreactor containing microorganisms configured to produce hydrocarbon fuels. Additionally, the present disclosure also relates to systems for the production of hydrocarbon fuels. A system may include a pretreatment system, a first separation system, a hydrolysis system, a second separation system, and one or more bioreactors.

Abstract: The present invention provides to a process for recovery of an organic compound (i.e. Ethanol, propanol, butanol, Acetone, iso-propyl alcohol) from a fermented broth which is produced from different fermentation technologies. The present invention particularly relates to an integrated process for ethanol separation from the fermentation broth using integrated vapor compressing unit (turbofans), evaporator (falling film) and a broth stripper column (vacuum distillation system). The process is operated under low temperature for the separation and recovery of the organic compound (particularly ethanol) from the fermented broth containing live microbes typically below or at 50° C. to ensure the activity of the microbes in the broth recycle. Again, the activity of the microbes is further ensured by maintaining the residence time of the microbe containing broth outside the Fermentor is less than or equal to 10 minutes.

Abstract: The invention relates to a method for obtaining a mineral substance from a base comprising mineral matter, the method comprising obtaining the base comprising a predetermined quantity of the mineral matter synthesised by a living structure or a portion of the latter, characterised in that obtaining the base comprises providing the living structure and providing at least one lactic acid microorganism suitable for symbiosis with the living structure for the synthesis of the mineral matter of the mineral substance. The invention also relates to a mineralising composition comprising a living structure, a lactic acid microorganism, a nutritive substance; the mineral substance used in the method; and the use of a combination of a living structure and a lactic acid microorganism in symbiosis with each other as a mineralising agent in a self-regenerating material.

Abstract: The present invention provides a nerve cell device in which early observation of nerve activity (spikes, bursts, and the like) is made possible and the measured electric strength is increased by cultivating neurons upon a cell scaffold. By using this nerve cell device, imaging of intracellular signaling is also possible.

Abstract: Provided herein are compositions and methods for production of organic acids. In particular, provided herein are consolidated bioprocessing compositions and methods for single reactor production of organic acids.

Abstract: Strain of Bacillus thuringiensis novonest4 and applications thereof. The Bacillus thuringiensis is the Bacillus thuringiensis novonest4, with an Accession No. CCTCC NO: M2018443. The strain is firstly reported to have both the effect of preventing and controlling lepidoptera pests after foilar application and the effects of degrading carbendazim, promoting crop growth and increasing crop yield after soil application, and has wide application prospects in agricultural production.

Abstract: The invention provides a method and bacterial compositions for reducing or preventing an infection of a bodily tissue by a fungal microorganism by contacting the tissue with a composition comprising a purified Lactobacillus paracasei bacterium.

Abstract: The present invention provides a method for making a consortium of fungi resistant to traces of carbamates contained in thiodicarb and to traces of synthetic pyrethroids contained in bifenthrin. During the course of this research, carried out over more than five years, the strains were subjected to a change in physical medium, adapting same to tolerate increasing concentrations of thiodicarb and bifenthrin. This compound enriches and increases the concentration of beneficial microorganisms, generating high-quality liquid biological fertilisers suitable for use in agricultural production, in land recovery and conservation, under the parameters established in sustainable organic farming, which seeks to conserve, recover and use nature or the environment without generating the least negative impact.

Abstract: The consortium comprises the Clostridium pasteuranium. Bacillis thuringiensis, Bacillus megaterium, Bacillus btilis, Azotobacter vinelandii and Rhizobium sp micro-organisms, which are subjected to increasing concentrations of thiodicarb and biphenthrin in order to render them tolerant to these compounds without manipulating their genome. The use of the consortium in the form of a liquid biofertiliser enriches the soil with bacteria which, besides being resistant to thiodicarb and biphenthrin, capture atmospheric nitrogen, solubilise phosphor and act against some pathogens.

Abstract: Provided herein are methods for producing one or more polyunsaturated fatty acids. The methods include the steps of providing a microorganism capable of producing polyunsaturated fatty acids, providing a medium comprising a high concentration of one or more carbon sources, low pH, or both, and culturing the microorganism in the medium under sufficient conditions to produce the one or more polyunsaturated fatty acids. Also provided are methods of culturing one or more microorganisms. The methods include culturing the microorganisms in a medium comprising a first amount of one or more carbon sources at a first concentration level, monitoring a carbon source concentration until the carbon source concentration is reduced below the first concentration level, and adding to the medium a second amount of one or more carbon sources to increase the carbon source concentration to a second concentration level.

Abstract: What is described is a kit for preparing a liquid thromboplastin reagent for a prothrombin time assay. The kit simplifies and minimizes reagent preparation time and is stable for 2-5 years.

Abstract: The application belongs to the field of biotechnology and microbiology, in particular to a strain of Streptomyces roseoverticillatus (Sr-63) which antagonizes the Rice Bacterial Blight and its application in the prevention and treatment of plant diseases. The application discloses a strain of S. roseoverticillatus (Sr-63) with the accession number CCTCC No.: M 2019261. It is also disclosed the application of the S. roseoverticillatus (Sr-63): used for controlling Rice Bacterial Blight.

Abstract: Disclosed is a process for obtaining monosaccharides in acid aqueous solution from chitin or chitosan by means of chemical and/or enzymatic hydrolysis. By using low-cost and easily obtainable reagents, this process makes it possible to obtain sugar solutions of industrial importance. With our new production process to supply the food industry and/or the chemicals industry, manufacturing of monosaccharides is less complex and thus technically and financially more viable.

Abstract: The disclosure is concerned with a novel human intestinal isolate capable of converting L-lysine into butyrate and/or of converting fructose-lysine into butyrate. The novel isolate can be used as a probiotic or supplement to promote production of butyrate in the GI tract, thereby preventing and/or treating conditions or diseases that benefit from the production of butyrate. Additionally, the isolate may prevent and/or treat conditions or diseases caused by an excess of pathogenic bacteria in the GI tract, mediated by L-lysine, or mediated by fructose-lysine or other advanced glycation end products.

Abstract: The present invention provides, inter alia, methods for treating or ameliorating an effect of a solid tumor present in a human. These methods include administering intratumorally to the human a unit dose of C. novyi, preferably C. novyi NT, colony forming units (CFUs), which contains about 1×103-1×107 CFUs suspended in a pharmaceutically acceptable carrier or solution. Methods for debulking a solid tumor present in a human, methods for ablating a solid tumor present in a human, a method for microscopically precise excision of tumor cells in a human, methods for treating or ameliorating an effect of a solid tumor that has metastasized to one or more sites in a human, unit doses of C. novyi, preferably C. novyi NT, CFUs, and kits for treating or ameliorating an effect of a solid tumor present in a human are also provided.

Abstract: Methods of production of edible filamentous fungal biomat formulations are provided as standalone protein sources and/or protein ingredients in foodstuffs as well as a one-time use or repeated use self-contained biomat reactor comprising a container with at least one compartment and placed within the compartment(s), a feedstock, a fungal inoculum, a gas-permeable membrane, and optionally a liquid nutrient medium.

Abstract: Described herein are avian follistatin products, and methods for producing such products, in which such products are effective for a variety of conditions, including increasing muscle mass. Avian follistatin products described herein are packaged as dietary supplements or nutritional supplements are useful in muscle regeneration.

Abstract: Methods and apparatus for rapid, culture free pathogen detection. The methods utilize optical spectroscopy techniques to identify and/or characterize pathogens in a sample via the detection of unique properties and/or analytes that are specific to particular pathogens.

Abstract: Described is a novel human intestinal isolate capable of converting L-lysine into butyrate and/or of converting fructose-lysine into butyrate. The novel isolate can be used as a probiotic or supplement to promote production of butyrate in the GI tract, thereby preventing and/or treating conditions or diseases that benefit from the production of butyrate. Additionally, the isolate may prevent and/or treat conditions or diseases caused by an excess of pathogenic bacteria in the GI tract, mediated by L-lysine, or mediated by fructose-lysine or other advanced glycation end products.

Abstract: Methods of and system for growing and maintaining an optimized/ideal active yeast solution in the yeast tank and fermenter tank during the fermentation filling cycle are provided. A new yeast stage tank is used between the yeast tank and the fermenter tank allowing yeast to rapidly produce a huge amount of active young yeast cells for a fermenter during the filling period. A measurable and useful controlling factor, % DT/% Yeast by weight ratio (or “food” to yeast ratio), is used (e.g., % DT=glucose), which offers information on the health status of the yeast. The controlling factor is used to control the status of the yeast throughout the entire process.